Amphastar Pharmaceuticals, Inc. (AMPH) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Amphastar Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 12.76x | 11.27x | 21.70x | 14.89x | 17.91x | 674.22x |
| P/B Ratio | 1.59x | 2.46x | 4.67x | 2.57x | 2.50x | 2.35x |
| P/S Ratio | 1.74x | 2.46x | 4.63x | 2.73x | 2.54x | 2.70x |
| Profitability | ||||||
| Gross Margin | 49.5% | 51.1% | 54.5% | 49.9% | 45.6% | 41.0% |
| Operating Margin | 19.5% | 28.1% | 30.6% | 21.5% | 16.0% | 3.1% |
| Net Margin | 13.6% | 21.8% | 21.3% | 18.3% | 14.2% | 0.4% |
| EBITDA Margin | 20.7% | 37.9% | 37.3% | 29.3% | 25.5% | 8.6% |
| Liquidity | ||||||
| Current Ratio | 4.02x | 3.07x | 2.17x | 3.99x | 3.06x | 2.49x |
| Quick Ratio | 2.90x | 2.19x | 1.70x | 2.90x | 2.17x | 1.63x |
| Leverage | ||||||
| Debt/Equity | 0.83x | 0.89x | 0.98x | 0.19x | 0.23x | 0.17x |
YoY = year-over-year change. Source: FMP..